首页> Nature communications> Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.

导出 OA

翻译打印收藏纠错

第一作者： Bo,Zhang

第一单位： Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

作者： Bo,Zhang ^[1] ; Youyi,Fong ^[2] ; Lauren,Dang ^[3] ; Jonathan,Fintzi ^[3] ; Shiyu,Chen ^[1] ; Jing,Wang ^[4] ; Nadine G,Rouphael ^[5] ; Angela R,Branche ^[6] ; David J,Diemert ^[7] ; Ann R,Falsey ^[6] ; Daniel S,Graciaa ^[5] ; Lindsey R,Baden ^[8] ; Sharon E,Frey ^[9] ; Jennifer A,Whitaker ^[10] ; Susan J,Little ^[11] ; Satoshi,Kamidani ^[12] ; Emmanuel B,Walter ^[13] ; Richard M,Novak ^[14] ; Richard,Rupp ^[15] ; Lisa A,Jackson ^[16] ; Chenchen,Yu ^[1] ; Craig A,Magaret ^[1] ; Cindy,Molitor ^[1] ; Bhavesh,Borate ^[1] ; Sydney,Busch ^[17] ; David,Benkeser ^[17] ; Antonia,Netzl ^[18] ; Derek J,Smith ^[18] ; Tara M,Babu ^[19] ; Angelica C,Kottkamp ^[20] ; Anne F,Luetkemeyer ^[21] ; Lilly C,Immergluck ^[22] ; Rachel M,Presti ^[23] ; Martín,Bäcker ^[24] ; Patricia L,Winokur ^[25] ; Siham M,Mahgoub ^[26] ; Paul A,Goepfert ^[27] ; Dahlene N,Fusco ^[28] ; Robert L,Atmar ^[10] ; Christine M,Posavad ^[29] ; Jinjian,Mu ^[30] ; Mat,Makowski ^[30] ; Mamodikoe K,Makhene ^[31] ; Seema U,Nayak ^[31] ; Paul C,Roberts ^[31] ; Peter B,Gilbert ^[2] ; Dean,Follmann ^[32] ; Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team

作者单位： Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. ^[1] Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.;Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.;Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA, USA. ^[2] Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. ^[3] Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. ^[4] Hope Clinic, Emory University, Decatur, GA, USA. ^[5] Vaccine and Treatment Evaluation Unit, University of Rochester, Rochester, NY, USA. ^[6] George Washington Vaccine Research Unit, George Washington University, Washington, DC, USA. ^[7] Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ^[8] Center for Vaccine Development, Saint Louis University, St Louis, MO, USA. ^[9] Department of Molecular Virology and Microbiology and Department of Medicine, Baylor College of Medicine, Houston, TX, USA. ^[10] Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, CA, USA. ^[11] Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, GA, USA.;Department of Pediatrics, Emory University, Atlanta, GA, USA. ^[12] Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA. ^[13] Project WISH, University of Illinois at Chicago, Chicago, IL, USA. ^[14] Department of Pediatrics, University of Texas Medical Branch, Galveston, TX, USA. ^[15] Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA. ^[16] Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA. ^[17] Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UK. ^[18] Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA. ^[19] Vaccine and Treatment Evaluation Unit, Manhattan Research Clinic, New York University Grossman School of Medicine, New York, NY, USA. ^[20] Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, CA, USA. ^[21] Clinical Research Center, Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA.;Biological Sciences Division, The University of Chicago, Chicago, IL, USA. ^[22] Department of Medicine, Washington University School of Medicine, St Louis, MO, USA. ^[23] Department of Internal Medicine, University of Utah Schoole of Medicine, Salt Lake City, Utah, USA. ^[24] Department of Medicine, University of Iowa College of Medicine, Iowa City, IA, USA. ^[25] Howard University College of Medicine, Howard University Hospital, Washington, DC, USA. ^[26] Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. ^[27] Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA. ^[28] Infectious Diseases Clinical Research Consortium (IDCRC) Laboratory Operations Unit, Fred Hutchinson Cancer Center, Seattle, WA, USA.;Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA. ^[29] The Emmes Company LLC, Rockville, MD, USA. ^[30] Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. ^[31] Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. dfollmann@niaid.nih.gov. ^[32]